Evidence map›Paper›PMID 37874783›Full record

ArticlePLOS global public health2023

Facilitators and barriers to COVID-19 testing in community and clinical settings: Lessons learned from Lesotho and Zambia.

Musonda Simwinga, Palesa A Mahlatsi, Masemote Molale, Gracious Witola, Isaac Mshanga, Bulemba Katende, Alain Amstutz, Klaus Reither, Kwame Shanaube, Masetsibi Motlomelo and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Musonda SimwingaZambart, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-0684-6897
Palesa A MahlatsiSolidarMed, Partnerships for Health, Maseru, Lesotho.
Masemote MolaleNational University of Lesotho, Roma, Lesotho.ORCID https://orcid.org/0000-0003-3985-6773
Gracious WitolaZambart, Lusaka, Zambia.ORCID https://orcid.org/0000-0001-9839-4826
Isaac MshangaZambart, Lusaka, Zambia.
Bulemba KatendeSolidarMed, Partnerships for Health, Maseru, Lesotho.ORCID https://orcid.org/0000-0002-4562-0612
Alain AmstutzUniversity of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-1716-993X
Klaus ReitherSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Kwame ShanaubeZambart, Lusaka, Zambia.
Masetsibi MotlomeloSolidarMed, Partnerships for Health, Maseru, Lesotho.
Virginia BondZambart, Lusaka, Zambia.
Jennifer M BelusUniversity of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-4091-4889
Zambart · ZMUniversity of Basel · CHLondon School of Hygiene & Tropical Medicine · GBNational University of Lesotho · LSSwiss Tropical and Public Health Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sudden emergence of the coronavirus disease 2019 (COVID-19) had a devastating impact on health systems and population health globally. To combat the spread of COVID-19, countries enacted guidelines and safety measures, including testing, contact tracing, and quarantine. It was unclear the extent to which uptake of COVID-19 testing and other health initiatives would be accepted in countries with a history of dealing with widespread communicable disease transmission such as HIV or Tuberculosis. The objective of this study was to understand and compare the facilitators and barriers to COVID-19 testing at hospital sites in two rural communities in Lesotho and community spaces (referred to as hubs) in one urban community in Zambia during active phases of COVID-19 pandemic. Individual interviews and focus group discussions (FGDs) were held during March-October 2021 to explore facilitators and barriers to COVID-19 testing. FGDs with 105 community members and health care workers, and 16 individual interviews with key informants and four mystery shoppers were conducted across the two countries. In Zambia, four mystery shopper observations, and eight hub observations were also conducted. Individual country codebooks were developed and combined; thematic analyses were then conducted using the combined codebook. Findings were compared across the two countries, and most were consistent across the two countries. Two primary themes emerged that related to both barriers and facilitators: (1) structural conditions; (2) social implications and attitudes. The structural conditions that operated as barriers in both countries included public health isolation measures and misinformation. In Lesotho, the cost of tests was an additional barrier. The only structural facilitators were in Zambia where the community hubs were found to be accessible and convenient. The social implication barriers related to fear of isolation, stigma, and mental health implications because of quarantine, perceived pain of the test, and compromised privacy. Social facilitators that led to people testing included experiencing COVID-19 firsthand and knowing people who had died because of COVID-19. Across both countries, primary barriers and facilitators to COVID-19 related to structural conditions and social implications and attitudes. Public health measures can be at odds with social and economic realities; pandemic response should balance public health control and the socio-economic needs. Data from Zambia revealed that community-based settings have the potential to increase uptake of testing services. Community-based campaigns to normalize and reduce stigma for COVID-19 testing services are needed.

Identifiers

PMID37874783
PMCPMC10597474
OpenAlexW4387909673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.